Analyze HALO
Indicators
Fundamentals
Market cap
$9.91B
Institutional
Short interest
Analyst target
Annual revenue
$1.40B
▲ +37.6%YoY
Annual net income
$316.89M
▼ -28.6%YoY
Share count
A question the system examines through the data — not advice
Halozyme Therapeutics, Inc. (HALO) is trading around $103.12 (+20.24% on the last session). Its 52-week range runs from $61.23 to $103.30. Technically: 9 buy signals, 3 sell and 0 neutral. It belongs to the Healthcare sector (Biotechnology), with a P/E of 30.2 and a 12B$ market cap. Data sourced from Live price as of 23:00. This is data analysis only, not advice or a recommendation.
Disclosure & disclaimer: All information, scores, signals and trade plans on this site are produced by an automated algorithmic system and are based on technical and quantitative data only. They do not constitute investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional that accounts for your needs and circumstances. We are not investment advisors. Trading securities involves substantial risk, up to the loss of your entire investment; every decision and action is your sole responsibility. analysto and its operators bear no liability for any direct or indirect damage arising from reliance on this information.
123.90M
▼ -4.3%YoY
Strong buy signal
From 13 weighted indicators
Daily & weekly aligned · Positive but stretched — pullback risk · Overbought · Stretched above band
13 indicators under fixed, disclosed rules on closed daily bars, each carrying its own weight in the score. Not investment advice or a recommendation.